Diagnostic Test Accuracy Protocol

You have free access to this content

CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

  1. Craig Ritchie1,*,
  2. Nadja Smailagic2,
  3. Emma C Ladds3,
  4. Anna H Noel-Storr4,
  5. Obioha Ukoumunne5,
  6. Steven Martin2

Editorial Group: Cochrane Dementia and Cognitive Improvement Group

Published Online: 26 OCT 2013

DOI: 10.1002/14651858.CD010803


How to Cite

Ritchie C, Smailagic N, Ladds EC, Noel-Storr AH, Ukoumunne O, Martin S. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI) (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD010803. DOI: 10.1002/14651858.CD010803.

Author Information

  1. 1

    Imperial College London, London, UK

  2. 2

    University of Cambridge, Institute of Public Health, Cambridge, UK

  3. 3

    John Radcliffe Hospital, Oxford University Medical School, Oxford, UK

  4. 4

    University of Oxford, Radcliffe Department of Medicine, Oxford, UK

  5. 5

    University of Exeter Medical School, University of Exeter, Peninsula CLAHRC, Exeter, Devon, UK

*Craig Ritchie, Imperial College London, London, UK. c.ritchie@imperial.ac.uk.

Publication History

  1. Publication Status: New
  2. Published Online: 26 OCT 2013

SEARCH

References

Additional references

Albert 2011
  • Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendation from the National Institute on Ageing and Alzheimer’s Association workgroup. Alzheimer’s & Dementia 2011;7(3):270-9.
Beckett 2010
  • Beckett LA, Harveya DJ, Gamst A, Donohueb M, Kornak J, Zhang H. The Alzheimer’s Disease Neuroimaging Initiative: annual change in biomarkers and clinical outcomes. Alzheimer’s & Dementia 2010;6:257-64.
Billingsley 1997
  • Billingsley ML, Kincaid RL. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. The Biochemical Journal 1997;323(3):577-91.
Birks 2006
Blennow 2003
  • Blennow K, Hampel H. CSF markers for incipient Alzheimer's disease. Lancet Neurology 2003; Vol. 2, issue 10:605-13.
Bossuyt 2008
  • Bossuyt PM, Leeflang MM. Chapter 6: Developing Criteria for Including Studies. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy 2008:Version 0.4 [updated September 2008].
Bourne 2007
  • Bourne J. Improving Services and Support for People with Dementia. National Audit Office 2007.
Boxer 2005
Bruscoli 2004
Dubois 2010
  • Dubois B, Feldman HH, Jacova C, Cummings JL, Dekosky ST, Barberger-Gateau P, et al. Revising the definition of Alzheimer's disease: a new lexicon. Lancet Neurology 2010;9(11):1118-27.
Ferri 2005
  • Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366(9503):2112-17.
Geslani 2005
  • Geslani D, Tierney M, Herrmann N, Szalai J. Mild cognitive impairment: an operational definition and its conversion rate to Alzheimer's disease. Dementia and Geriatric Cognitive Disorders 2005;19:383-9.
Glanville 2010
  • Glanville JM, Cikalo M, Crawford F, Dozier M, Lowson P. Handsearching for reports of diagnostic test accuracy studies: adding to the evidence base. Cochrane Database of Systematic Reviews Supplement 2010, issue CD000002:48.
Greenhalgh 2005
  • Greenhalgh T, Peacock R. Effectiveness and efficiency of search methods in systematic reviews of complex evidence: audit of primary sources. BMJ 2005; Vol. 331:1064-5.
Knapp 2007
  • Knapp M, Prince M. Dementia UK: A Report to the Alzheimer's Society on the Prevalence and Economic Cost of Dementia in the UK. King's College London and London School of Economics. Alzheimer's Society 2007.
Knopman 2001
  • Knopman D, DeKosky S, Cummings J, Chui H, Corey-Bloom J, Relkin N, et al. Practice parameter: diagnosis of dementia (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 2001;56(9):1143-53.
Knottnerus 2002
Leeflang 2006
  • Leeflang MM, Scholten RJ, Rutjes AW, Reitsma JB, Bossuyt PM. Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. Journal of Clinical Epidemiology 2006; Vol. 59, issue 3:234-40.
LMG 1994
  • The Lund and Manchester Groups. Clinical and neuropathological criteria for frontotemporal dementia. Journal of Neurology, Neurosurgery, and Psychiatry 1994;57(4):416-8.
Macaskill 2010
  • Macaskill P, Gatsonis C, Deeks J, Harbord, R, Takwoingi Y. Chapter 10: Analysing and Presenting Results. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0. The Cochrane Collaboration 2010; Vol. Available from: http://srdta.cochrane.org/.
Mandelkow 1998
Matthews 2008
  • Matthews FE, Stephan BC, McKeith IG, Bond J, Brayne C. Medical Research Council Cognitive Function and Ageing Study. Two-year progression from mild cognitive impairment to dementia: to what extent do different definitions agree?. Journal of the American Geriatrics Society 2008; Vol. 56, issue 8:1424-33.
Matthews 2009
  • Matthews FE, Brayne C, Lowe J, McKeith I, Wharton SB, Ince P. Epidemiological pathology of dementia: attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study. PLoS Medicine 2009;6:e1000180.
Mattson 2009
  • Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA 2009;302(4):385-93.
McKeith 1996
  • McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; Vol. 47, issue 5:1113-24.
McKeith 2005
McKhann 1984
  • McKhann GM, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; Vol. 34, issue 7:939-44.
McKhann 2011
  • McKhann GM, Knopman DS, Chertkow H, Hyman BT, Clifford RJ, Kawas CH, et al. The diagnosis of dementia due to Alzheimer’s disease: recommendation from the National Institute on Ageing and Alzheimer’s Association workgroup. Alzheimer’s & Dementia 2011; Vol. 7, issue 3:263-9.
McShane 2006
Morris 1993
  • Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993;43:2412-14.
MRC CFAS 2001
  • MRC CFAS. Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS) [Lancet]. 2001; Vol. 357, issue 9251:169-75.
Neary 1998
  • Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-54.
Noel-Storr 2013
  • Noel-Storr AH, Flicker L, Ritchie CW, Nguyen GH, Gupta T, Wood P, et al. Systematic review of the body of evidence for use of biomarkers in the diagnosis of dementia. Alzheimer’s & Dementia 2013;9(3):e96-e105.
Okello 2009
  • Okello A, Koivunen J, Edison P, Archer HA, Turkheimer F, Nagren K, et al. Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology 2009;73(10):754-60.
Petersen 1999
  • Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Archives of Neurology 1999; Vol. 56:303-8.
Petersen 2004
Petersen 2009
  • Petersen RC, Roberts RO, Knopman DS, Boeve BF, Geda YE, Ivnik RJ, et al. Mild cognitive impairment: ten years later. Archives of Neurology 2009;66(12):1447-55.
Petersen 2010
  • Petersen R, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 2010;74(3):201-9.
Quinn 2012
  • Quinn TJ, McShane R, Fearon P, Young C, Noel-Storr A, Stott DJ. IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community setting. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010079]
Ritchie 2011
  • Ritchie C, Masters CL, Mason SE, Li QX, McShane R. Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia. Cochrane Database of Systematic Reviews 2011, Issue 1. [DOI: 10.1002/14651858.CD008782.pub3]
Ritchie 2013
  • Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SA, McShane. Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementia. Cochrane Database of Systematic Reviews Ongoing review.
Roman 1993
  • Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; Vol. 43, issue 2:250-60.
Rutter 2001
Savva 2009
Shoji 1992
Shoji 2001
  • Shoji M, Kanai M. Cerebrospinal fluid Ab40 and Ab42: natural course and clinical usefulness. Journal of Alzheimer's Disease 2001;3(3):313-21.
Shoji 2002
  • Shoji M, Matsubara E, Murakami T, et al. Cerebrospinal fluid tau in dementia disorders: a large scale multicenter study by a Japanese study group. Neurobiology of Aging 2002; Vol. 23, issue 3:363-70.
Sperling 2011
  • Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, et al. Toward defining the preclinical stages of Alzheimer’s disease: recommendation from the National Institute on Ageing-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia 2011;7(3):280-92.
Visser 2006
Whiting 2011a
  • Whiting P, Westwood M, Beynon R, Burke M, Sterne JA, Glanville JI. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. Journal of Clinical Epidemiology 2011;64:602-7.
Whiting 2011b
  • Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Annals of Internal Medicine 2011;155:529-36.
Wilmo 2010
  • Wilmo A, Prince M. World Alzheimer Report 2010: The Global Economic Impact of Dementia. Available at http://www.alz.co.uk/research/files/WorldAlzheimerReport2010.pdf 2010.
Winbald 2004
World Health Organization 2010
  • World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD-10 Version: 2010). http://apps.who.int/classifications/icd10/browse/2010/en (accessed 9 January 2013).